Barak M, Ulitzur S, Merzbach D
J Clin Microbiol. 1983 Aug;18(2):248-53. doi: 10.1128/jcm.18.2.248-253.1983.
Nonmarine luminous bacteria belonging to the genus Vibrio cholerae were extremely sensitive to the bactericidal activity of human serum. Luminous bacteria incubated in a medium containing serum showed a decrease in their in vivo luminescence that was directly proportional to the decrease in the viable count and was a function of the serum concentration. Both immunoglobulins and the complement system were required to exert the serum bactericidal activity. Serum lacking immunoglobulins or certain complement components, especially C3, did not affect the luminescence. The bactericidal effect of the serum on luminous bacteria was diminished by the presence of lipopolysaccharide or by pretreatment of the serum with different species of killed bacteria. As found in other systems, the bacteriolytic activity of serum was only augmented by lysozyme, but was not lysozyme dependent; although the luminous bacteria were converted into spheroplasts in serum containing 0.5 M sucrose, their in vivo luminescence was almost not affected. This system could easily distinguish between the C classical pathway and the properdin pathway. Ethylene glycol-bis (beta-aminoethyl ether)-N,N'-tetraacetic acid, which inhibits only the classical complement pathway, did not inhibit the decrease in luminescence as did EDTA. Thus, it was possible to distinguish between deficiencies in complement components participating in both pathways and complement components that were involved only in the classical pathway. This system could also be used as a substitute to the hemolytic system in complement fixation tests.
属于霍乱弧菌属的非海洋发光细菌对人血清的杀菌活性极为敏感。在含有血清的培养基中培养的发光细菌,其体内发光强度降低,这与活菌数的减少成正比,且是血清浓度的函数。免疫球蛋白和补体系统都需要发挥血清杀菌活性。缺乏免疫球蛋白或某些补体成分,尤其是C3的血清,不会影响发光。血清中存在脂多糖或用不同种类的死菌预处理血清会减弱血清对发光细菌的杀菌作用。正如在其他系统中所发现的,血清的溶菌活性仅被溶菌酶增强,但不依赖于溶菌酶;尽管发光细菌在含有0.5M蔗糖的血清中转化为原生质球,但其体内发光几乎不受影响。该系统可以很容易地区分补体经典途径和备解素途径。仅抑制经典补体途径的乙二醇双(β-氨基乙基醚)-N,N'-四乙酸不像EDTA那样抑制发光强度的降低。因此,有可能区分参与两条途径的补体成分缺陷和仅参与经典途径的补体成分缺陷。该系统也可在补体结合试验中用作溶血系统的替代物。